The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
The surprising reason why Americans could face high beef prices for years
Breaking the Fourth Wall: Left-wing groups defiant as GOP sheds light on groups tied to China
Grand jury rejects DOJ effort to indict Democratic lawmakers who urged military to defy illegal orders
Key House committee advances nationwide voter ID bill, setting up 2026 election fight
What the timing of the FBI’s image release suggests in the Nancy Guthrie case: crime insider
Dem senator fumes that GOP’s foreign funding claim ‘delegitimizes’ anger of anti-ICE agitators in US
Susan Collins shrugs off attacks by Democrats and Trump, says Maine voters ‘Don’t vote party line’
DOJ Unredacts Alleged Epstein Co-Conspirators After Pressure from Thomas Massie and Ro Khanna
Leavitt brushes off Lutnick–Epstein heat with list of administration wins media ignored before ending briefing
Media Reporting Trump’s Tariffs Cost Americans $1,000, But They’re Ignoring Overall Savings of His Policies
Dem lawmaker compares ICE agents to Nazis and Gestapo during fiery House hearing on enforcement
Senate GOP investigating Pritzker administration over Illinois health records breach
Major charity raises legal questions by funding pro-Harris dark money operation
Fulton County FBI raid prompted by Trump 2020 election lawyer’s criminal referral
AI power players pour cash into competitive primaries as 2026 midterms heat up
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
The surprising reason why Americans could face high beef prices for years
Breaking the Fourth Wall: Left-wing groups defiant as GOP sheds light on groups tied to China
Grand jury rejects DOJ effort to indict Democratic lawmakers who urged military to defy illegal orders
Key House committee advances nationwide voter ID bill, setting up 2026 election fight
What the timing of the FBI’s image release suggests in the Nancy Guthrie case: crime insider
Dem senator fumes that GOP’s foreign funding claim ‘delegitimizes’ anger of anti-ICE agitators in US
Susan Collins shrugs off attacks by Democrats and Trump, says Maine voters ‘Don’t vote party line’
DOJ Unredacts Alleged Epstein Co-Conspirators After Pressure from Thomas Massie and Ro Khanna
Leavitt brushes off Lutnick–Epstein heat with list of administration wins media ignored before ending briefing
Media Reporting Trump’s Tariffs Cost Americans $1,000, But They’re Ignoring Overall Savings of His Policies
Dem lawmaker compares ICE agents to Nazis and Gestapo during fiery House hearing on enforcement
Senate GOP investigating Pritzker administration over Illinois health records breach
Major charity raises legal questions by funding pro-Harris dark money operation
Fulton County FBI raid prompted by Trump 2020 election lawyer’s criminal referral
AI power players pour cash into competitive primaries as 2026 midterms heat up
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
